Taken together, these observations suggest that ADO plays an important role in modulating the activity of tumor-infiltrating myeloid cells by limiting their capacity to evoke anti-tumor immune responses and are potential targets for therapeutic intervention. The gene discussed is ADO; the disease is neoplasm.